Medical Devices & Surgical Technology Week articles from November 2003

Medical Devices & Surgical Technology Week archives from November 2003

Surgical obesity treatment reduces risk of musculoskeletal pain.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Surgical obesity treatment reduces the risk of musculoskeletal pain. According to recent research from Sweden, "Obesity is associated With musculoskeletal pain and osteoarthritis. This study...

Polyethylene wear acetabular cup monitoring by digitized radiography evaluated.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Polyethylene wear acetabular cup monitoring by digitized radiography is evaluated. "The aim of this study was to assess polyethylene wear in a total hip prosthesis by digitized radiography of the...

A hybrid breast biopsy system combines ultrasound and MRI.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A hybrid breast biopsy system combines ultrasound and MRI. "System design and initial phantom accuracy results for a novel biopsy system integrating both magnetic resonance (MR) and ultrasound (US)...

Fusion between recipient- and donor-derived cells is a rare occurrence.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Fusion between recipient- and donor-derived cells is a rare occurrence. "Despite recent advances in immunosuppressive therapy, accelerated coronary atherosclerosis remains a major problem in the...

Gene expression changes evaluated in an in vitro model of chondroinduction.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Gene expression changes are evaluated in an in vitro model of chondroinduction. According to published research from the United States, "There are many useful technologies to describe patterns of...

Bioartificial liver support systems bridge the transplantation gap.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Bioartificial liver support systems bridge the transplantation gap. "Fulminant hepatic failure (FHF) is an important cause of death worldwide. Despite significant improvements in critical care...

Chemical shift MRI was found to be useful for identifying adenomas in most cases.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Chemical shift MRI was found to be useful for identifying adenomas in most cases. According to a study from Japan, "Chemical shift MRI is widely used for identifying adenomas, but it is not a...

Resection is the treatment of choice for adrenocortical tumors in childhood.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Resection is the treatment of choice for adrenocortical tumors in childhood. "Adrenocortical tumors (ACT) are rare in childhood. Determination of malignant potential is difficult. To assess the...

DNA identification kit launched.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Exegetics, Inc., announced the release of the Print ID Kit and PrintID card, the "first of its kind" DNA sampling kit. The kit, designed to be easy to use, non-invasive, and highly accurate,...

Early, accurate diagnosis of AD possible with urine sample.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Alzheimer disease (AD) is the leading cause of dementia in the elderly, afflicting an estimated 4 million people in the United States alone. This figure is expected to rise to 14 million or more as...

Demand grows for CO[subscript]2 laser angina therapy.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- More cardiac surgeons are discovering the long-term benefits of carbon dioxide (CO[subscript]2) Transmyocardial Laser Revascularization (TMR) therapy. The CO[subscript]2 TMR therapy is a treatment...

Cell-analysis company and University of Birmingham form research alliance.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Guava Technologies, Inc., a biotechnology company focused on providing cell analysis at the benchtop, and the department of chemical engineering at the University of Birmingham in the United Kingdom...

Single array launched for human genome expression analysis.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Affymetrix, Inc., (AFFX) announced that it is taking orders for its new GeneChip brand Human Genome U133 Plus 2.0 Array, offering researchers the protein-coding content of the human genome on a single...

Arterial ischemic stroke in neonates, infants, and children reviewed.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Arterial ischemic stroke in neonates, infants, and children is reviewed. "Conditions associated with arterial ischemic stroke (AIS) in children include congenital heart malformations, sickle cell...

Treatment and outcome of spinal dural arteriovenous fistulas are examined.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Treatment and outcome of spinal dural arteriovenous fistulae are examined. "Spinal dural arteriovenous fistula (dAVFs) are rare and often misdiagnosed entities. The choice between surgical treatment...

FDA grants premarket approval for ALERT Companion II.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- EP MedSystems, Inc., (EPMD) announced that it has received premarket approval (PMA) notification on its supplement application, from the U.S. Food and Drug Administration (FDA) for the ALERT Companion...

American and Briton win Nobel for medicine.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- American Paul C. Lauterbur and Briton Sir Peter Mansfield won the 2003 Nobel Prize for medicine for discoveries leading to a technique that reveals images of the body's inner organs. Magnetic...

Noncoronary stents introduced in U.S. and Europe.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Edwards Lifesciences Corporation (EW) announced the introduction of its premounted, balloon-expandable LifeStent Systems. The first two products in the line include the LifeStent SDS Biliary...

Biotech firm named finalist in U.S. Army competition for contract.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Epoch Biosciences, Inc., (EBIO), a provider of proprietary products that accelerate genomic analysis, announced that it has received formal notification from the U.S. Army Space and Missile Defense...

A new technique offers oligonucleotide immobilization for hybridization.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A new technique offers oligonucleotide immobilization for hybridization. According to new research from Turkey, "the aim of this study was to develop a nucleic acid sensor based on piezoelectric...

Medical device manufacturer closes blood analysis product line acquisition.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Thoratec Corporation (THOR) said that its International Technidyne Corporation (ITC) subsidiary has completed its previously announced asset purchase agreement to acquire the Immediate Response Mobile...

Serologic T. cruzi test suitable for field, blood bank use.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A novel assay can quickly and accurately detect the etiological agent of Chagas disease in blood. According to published research from Brazil, "A rapid serologic test for diagnosis of T. cruzi...

Patients with vertebral compression fractures show improvement in pilot study.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Orthovita, Inc., (VITA) announced that patients with osteoporotic vertebral compression fractures treated with Cortoss Synthetic Cortical Bone Void Filler, using the vertebroplasty surgical technique,...

Combination of 2D PAGE, MALDI-TOF-MS successful as global screening tool for CSF.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Combination of 2D PAGE and MALDI-TOF-MS is successful as an unbiased global screening tool for CSF. "Cerebrospinal fluid (CSF) has been rediscovered in the post-genomic era as a great source of...

New 3-D tortuosity metric seems to detect several kinds of abnormalities.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- New 3-D tortuosity metric seems to be effective in detecting kinds of blood vessel abnormalities. According to published research from the United States, "The clinical recognition of abnormal...

Mammography use declines when breast cancer risk is greatest.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Women are less likely to undergo mammograms after the age of 65, according to PULSE, a consumer-health survey conducted by Medstat, a business of The Thomson Corp. (TOC). This is cause for concern...

FDA reconsiders silicone-gel implants.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Eleven years after most use of silicone-gel breast implants was banned amid fears they were dangerous, the U.S. Food and Drug Administration (FDA) is considering letting them back on the U.S. market....

Agglutination tests distinguish brucellosis from TB and other disorders.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Agglutination tests distinguish brucellosis from tuberculosis and other disorders. "Brucellosis is a systemic infectious disease caused by Gram-negative bacilli, the genus Brucella, and clinical...

Computer model shows that bypass surgery is more cost-effective than stents.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Stanford University Medical Center researchers have developed a computer model showing that bypass surgery is more cost-effective in the long run than stents in patients with two or more blocked...

Company publishes results of gene therapy approach for colon cancer.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Scientists at Lorus Therapeutics, Inc., have published the results of experimental studies aimed at developing an anticancer gene therapy based on over-expression of a novel tumor-suppressor gene in...

Cardiac monitoring company inks agreement with pharmaceutical company.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT), (ERES), a provider of centralized electrocardiographic (ECG) collection and interpretation services, has received an agreement for more than $1.6 million in...

Echocardiography shows sustained improvement in PG, septal walls.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Echocardiography shows sustained improvement in PG, septal, and left ventricular posterior wall thicknesses. According to a study from Japan, "Percutaneous transluminal septal myocardial ablation...

Texan foreign-body retrieval device launched in Europe.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- IDev Technologies, Inc., (IDev) announced the commercial release of its CE-Marked Texan foreign-body retrieval device into the European market. The Texan is IDev's second product to be launched this...

Heart-health scanning device brought to China.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A CardioMag Imaging, Inc., (CMITM) system has been installed in Tianjin, China. The new cardiovascular diagnostic technique - described by physicians as a "totally safe, non-contact, highly...

NIH grant to be used for development of a collagen-based coil.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Collagen Matrix, Inc., announced that it has been awarded a 2-year, phase II Small Business Innovation Research (SBIR) grant in the amount of $930,000 from the U.S. National Institutes of Health (NIH)...

Agreement signed for cardiac safety monitoring services.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT, ERES), a provider of centralized electrocardiographic (ECG) collection and interpretation services, announced that it has received agreements for approximately $1.4...

Library license agreement signed for discovery of therapeutic antibodies.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Dyax Corp. (DYAX) announced that it has granted a non-exclusive license to its proprietary antibody phage display libraries for the discovery of therapeutic antibodies to MedImmune, Inc. (MEDI). ...

Genetics supersedes epigenetics in colon cancer phenotype.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Genetics supersedes epigenetics in colon cancer phenotype. According to published research from the United States, "A CpG island DNA methylator phenotype has been postulated to explain silencing of...

Data submitted to FDA for clearance to market test to monitor colon cancer.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- AMDL, Inc., (ADL) has filed with the U.S. Food and Drug Administration for clearance to market its unique, proprietary DR-70 tumor marker test for use as an aid in monitoring patients previously...

Multidetector row helical CT provides valuable anatomical information.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Multidetector row helical CT provides valuable anatomical information. According to recent research published in the journal Clinical Imaging, "The origin of the right inferior phrenic artery (RIPA)...

Initial results of the TRISVR Multi-Center Registry reported.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Chase Medical announced the initial results of the TRISVR (tri-saver), Surgical Ventricular Reconstruction (SVR) Multi-Center Clinical Registry, which were recently evaluated during the 7th Annual...

Lubrizol completes personal-care ingredients acquisition.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- The Lubrizol Corp. (LZ) has completed the acquisition of selected personal-care product lines from Amerchol Corp., a subsidiary of the Dow Chemical Co. Annualized revenues for the acquired product...

Biotech company receives cord blood to enhance stem-cell expansion technology.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Pluristem Life Sciences, Inc., (PLRS) has signed research and development cooperation agreements with major medical institutions in Israel to receive pluristem with cord blood (CB) to further the...

Same-day discharge appears safe in majority of transfemoral coronary stentings.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Same-day discharge appears safe in majority of transfemoral coronary stentings. According to recent research published in the journal Catheterization and Cardiovascular Interventions, "Percutaneous...

Device firm adds metered dose inhaler manufacturing capabilities.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Cardinal Health, Inc., (CAH) announced the addition of a metered dose inhaler (MDI) manufacturing line. The fully automated small-scale commercial line will be operational by October 2003 and will...

Global sales, marketing organization launched for biologics testing.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- BioReliance Corporation (BREL) announced that it has launched a global sales and marketing organization, now offering its biologics testing and manufacturing services on a comprehensive basis to clients...

Nanotechnology company consolidates marketing efforts.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- U.S. Global Nanospace, Inc., (USGA) issued the following corporate update detailing recent business and product developments of significance: Over the course of the past 12 months the company has...

SLICES maker reports on operations.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- MicroSignal Corp. (MSGL) reported significant progress since the company's announcement of an executive management restructuring on August 28, 2003. Robert Braner, interim president, stated, "With...

FDA panel recommends non-approval of laser angioplasty.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Spectranetics Corporation (SPNC) announced that the Circulatory System Devices Advisory Panel of the U.S. Food and Drug Administration (FDA) recommended non-approval of the company's Pre-Market Approval...

Statistical technique improves PCR nucleic acid analysis.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A novel statistical technique improves polymerase chain reaction (PCR)-based DNA and RNA analysis. "Real-time PCR is becoming the method of choice for precise quantification of minute amounts of...

ActiveCare DVT System now available.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Hill-Rom Co., Inc.'s ActiveCare DVT System is now available for use in hospitals and long-term care facilities to help battle deep vein thrombosis. Most who die from the condition are immobile...

Titanium surface topography affects behavior of osteoblast-like SaOS-2 cells.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Titanium surface topography affects behavior of osteoblast-like SaOS-2 cells. According to recent research published in the Journal of Dental Research, "Surface properties may affect the clinical...

Brain imaging helps to understand depression.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A pioneering research study using brain imaging has yielded new clues to help sufferers from severe depression who do not respond to conventional treatment. Around 5 million people in the U.K....

Regulatory plan reiterated after pre-PMA-S meeting with FDA.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Cyberonics, Inc., (CYBX) reiterated its plan to submit a depression PMA-Supplement (PMA-S) to the U.S. Food and Drug Administration (FDA). Cyberonics' Clinical and Regulatory personnel met with...

Inverness Medical acquires certain rapid-diagnostics assets.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Inverness Medical Innovations, Inc., (IMA), a provider of consumer healthcare and professional diagnostics products and developer of advanced medical devices, has acquired certain assets from Abbott...

Fetal diagnostic test combo shows promise.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- A new combination of blood tests and ultrasound can detect fetuses with Down syndrome sooner and more accurately than standard U.S. screening tests, offering mothers-to-be more peace of mind and more...

S. cerevisiae gene expression profiling clarifies drugs' antifungal activity.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Genome-wide S. cerevisiae expression profiling can help clarify the action of antifungal agents. "Antifungal compounds exert their activity through a variety of mechanisms, some of which are poorly...

PET scanning is expanding the horizons of oncology drug development.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- PET scanning is expanding the horizons of oncology drug development. According to a study from the United States, "Positron emission tomography (PET) allows three-dimensional quantitative...

Two NIH biodefense grants to be used for vaccine development.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- AlphaVax, Inc., has been awarded two U.S. National Institutes of Health (NIH) biodefense grants to develop new vaccines, using the company's proprietary technology, against two groups of disease-causing...

Medarex enters collaboration to develop fully human antibody therapeutics.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Medarex, Inc., (MEDX) and Trillium Therapeutics, Inc., (TTI), a privately held, Canadian biotechnology company, announced a collaboration for the development of fully human antibody therapeutics. ...

Chiropractic approach to ear infections described.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Ear problems can be excruciatingly painful, especially in children. With 10 million new cases every year, ear infections are the most common illness affecting babies and young children and the...

Magnetic fields guide brain surgery.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Electrical signals from nerves in the brain cause weak magnetic fields that can be measured by means of magnetoencephalography (MEG). A project supported by the Austrian Science Fund (FWF) has...

Researchers review optimal therapy for esophageal cancer.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers review optimal therapy for esophageal cancer. "Esophageal carcinoma is one of the most common cancers in the world and has an increasing incidence in Western civilization. As the...

Ohio contract research organization opens Munich office.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Medpace, Inc., a full-service contract research organization, announced the opening of their Munich, Germany, office. Medpace headquarters are located in Cincinnati, Ohio, and approximately 25% of...

$9.2 Million financing to be used for launch of bone repair products.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- OsteoBiologics, Inc., (OBI) has closed a $9.2 million financing to launch and commercialize OBI's proprietary products for bone and cartilage repair in arthroscopy and sports medicine, as well as for...

Anti-infectives drug firm raises UKP 25M.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Arrow Therapeutics, the London based anti-infectives drug discovery company, announced that it has raised more than UKP 21M in the first close of its Series B funding round. The second stage of...

Cholesterol-monitoring company reports on FY03, predicts continued growth.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Lifestream Technologies (KFL) has filed its annual report for its fiscal year ended June 30, 2003 (FY03). "With the recent infusion of capital, cost reductions in place, and distribution expanding,...

Colorado device company announces financing commitment.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- HealtheTech, Inc., (HETC) has received commitments for the purchase of approximately $8.0 million of newly issued common stock and warrants to purchase common stock in a private placement from a group...

Device firm improves cash position by 16%.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Fonar Corporation, The MRI Specialist, reported a net loss of $15.0 million on revenues of $52.9 million for fiscal 2003, as compared to a net loss of $22.9 million on revenues of $43.2 million for...

Diagnostic product manufacturer sells 5,000,000 shares of common stock.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- OraSure Technologies, Inc., (OSUR) has entered into an underwriting agreement for the sale by the company of 5,000,000 shares of common stock in a public offering under its shelf registration statement....

Diagnostics company announces $2M private placement.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Avitar, Inc., (AVR) announced that it entered into a $2,000,000 private placement, which raised gross proceeds of $1,000,000 in the first closing of convertible preferred stock and warrants. An...

Diagnostics company announces exchange offer.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO; BIO.B) announced that it has commenced a registered exchange offer to exchange $225 million aggregate principal amount of its 7.50% senior subordinated notes due 2013...

Hearing diagnostics, infant screening sales benefit from marketing initiative.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Bio-logic Systems Corp. (BLSC), a designer and marketer of computerized medical electro-diagnostic equipment and disposables, reported financial results for the fiscal 2004 second quarter and 6 months...

Home-care products company issues $100 million in senior notes.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Invacare Corp. (IVC) announced it has completed the sale of an aggregate of $100 million of senior notes, which consist of three series of maturities. The series A notes represent $50 million of the...

Imaging company reports continued revenue increase.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Molecular Imaging Corp. (MLRI), a provider of molecular imaging (MI) services to healthcare entities in the U.S., announced audited results for the fiscal year ended June 30, 2003. For the fiscal...

Imaging company updates fourth quarter guidance.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- CTI Molecular Imaging, Inc., (CTMI) announced that earnings for the fiscal fourth quarter and year ended September 30, 2003, will fall below prior expectations. Revenues are expected to approximate...

Marr Technologies increases investment in maker of HIV-screening test.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Calypte Biomedical Corp. (CYPT), the developer and marketer of two U.S. Food and Drug Administration (FDA)-approved HIV-1 antibody tests for use with urine samples, announced that Marr Technologies,...

Microarray company to trade on Amex.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Accelr8 Technology Corporation (ACLY) announced that its shares were expected to begin trading on the American Stock Exchange on or about October 9, 2003. Its new trading symbol will be (AXK). ...

Reagent company earns $3.7 million in net income in first quarter.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Immucor, Inc., (BLUD) a provider of automated instrument-reagent systems to the blood-transfusion industry, reported financial results for the fiscal first quarter ended August 31, 2003, and confirmed...

Respiratory care products company reports earnings.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Allied Healthcare Products, Inc., (AHPI) reported a net loss of $106,000 for the quarter ended June 30, 2003, compared with a net loss of $11.3 million for the quarter ended June 30, 2002. Revenues...

SEC declares oncology company's resale registration statement effective.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Cytogen Corporation (CYTO) announced that the U.S. Securities and Exchange Commission (SEC) has declared effective the resale registration statement on Form S-3 that the company filed with the SEC on...

Vaccine company withdraws previously announced financing.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- ID Biomedical Corp. announced it has withdrawn its previously announced public offering of 5,000,000 common shares. As a result of general market conditions in the biotechnology industry, the...

Vision company obtains first tranche of interim financing.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- InSite Vision, Inc., (ISV), an ophthalmic therapeutics, diagnostics, and drug-delivery company, has obtained the first $500,000 tranche of up to a potential total of $1 million in interim financing from...

Wellbutrin maker provides guidance on third quarter 2003 results.
November 2, 2003... 2003 NOV 2 - (NewsRx.com & NewsRx.net) -- Biovail Corporation (BVF) announced that while it has not completed a final compilation and analysis of its 2003 third quarter, preliminary results indicate that revenues will be below previously issued...